Related Experiment Video
Updated: Jun 14, 2025

Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland
Published on: June 7, 2019
Mechanisms that clear mutations drive field cancerization in mammary tissue
Marta Ciwinska1, Hendrik A Messal2, Hristina R Hristova2
1VIB-KULeuven Centre for Cancer Biology, Department of Oncology, Leuven, Belgium.
Abstract:
Oncogenic mutations are abundant in the tissues of healthy individuals, but rarely form tumours1-3. Yet, the underlying protection mechanisms are largely unknown. To resolve these mechanisms in mouse mammary tissue, we use lineage tracing to map the fate of wild-type and Brca1-/-;Trp53-/- cells, and find that both follow a similar pattern of loss and spread within ducts. Clonal analysis reveals that ducts consist of small repetitive units of self-renewing cells that give rise to short-lived descendants. This offers a first layer of protection as any descendants, including oncogenic mutant cells, are constantly lost, thereby limiting the spread of mutations to a single stem cell-descendant unit. Local tissue remodelling during consecutive oestrous cycles leads to the cooperative and stochastic loss and replacement of self-renewing cells. This process provides a second layer of protection, leading to the elimination of most mutant clones while enabling the minority that by chance survive to expand beyond the stem cell-descendant unit. This leads to fields of mutant cells spanning large parts of the epithelial network, predisposing it for transformation. Eventually, clone expansion becomes restrained by the geometry of the ducts, providing a third layer of protection. Together, these mechanisms act to eliminate most cells that acquire somatic mutations at the expense of driving the accelerated expansion of a minority of cells, which can colonize large areas, leading to field cancerization.
Insights
Healthy tissues prevent tumors despite abundant oncogenic mutations through three protective layers. These mechanisms eliminate most mutated cells but allow some to expand, potentially leading to field cancerization.
Area of Science:
- Cell biology
- Cancer research
- Developmental biology
Background:
- Oncogenic mutations are common in healthy tissues but rarely cause tumors.
- The protective mechanisms preventing tumor formation are not well understood.
Purpose of the Study:
- To investigate the protective mechanisms against oncogenic mutations in mouse mammary tissue.
- To understand how cells with mutations are eliminated or lead to tumor development.
Main Methods:
- Lineage tracing to track cell fate in wild-type and Brca1-/-;Trp53-/- mouse mammary tissue.
- Clonal analysis to study cell dynamics within mammary ducts.
Main Results:
- Mammary ducts contain self-renewing stem cells and short-lived descendants, providing a first protection layer by eliminating most new mutations.
- Tissue remodeling during estrous cycles offers a second protection layer, eliminating most mutant clones but allowing some to expand.
- Duct geometry imposes a third layer of protection, restraining clone expansion and leading to field cancerization in surviving clones.
Conclusions:
- Multiple layers of protection exist in mammary tissue to eliminate cells with oncogenic mutations.
- While most mutations are cleared, a minority can expand, leading to widespread mutant cell populations and predisposing tissue to cancer.
- Understanding these mechanisms is crucial for cancer prevention and treatment strategies.
More Related Videos
07:45Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Mutagenicity and Carcinogenicity
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...